-
Early Access Programs and Pricing and Reimbursement Agreements of Orphan Medicines in Portugal
Sep 9, 2025, 16:22 PM -
Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina
Sep 9, 2025, 16:22 PM -
Do Short-Term Outcome-Based Payments for Treatments Provide the Same Incremental Net Benefit As List Price Discounts?
Sep 9, 2025, 16:22 PM -
The Use of Oligometastatic Disease in Routine Radiology Practice: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
How Do Neurologists Perceive the Organization and Functioning of Care in Their Multiple Sclerosis Units?
Sep 9, 2025, 16:22 PM -
Comparing Clinical Benefit Criteria in Health Technology Assessment of Oncology Drugs in the Netherlands and Europe: Driving Real Value or Inequal Access?
Sep 9, 2025, 16:22 PM -
The Impact of Clinical Evidence on the Inclusion of Non-Small Cell Lung Cancer Drugs in Brazil's Supplementary Healthcare System
Sep 9, 2025, 16:22 PM -
Disability-Associated Economic Burden Among Patients With Wilson’s Disease in South Korea: A Nationwide Cost-of-Illness Study
Sep 9, 2025, 16:22 PM -
Budget Impact of an Ambulatory Minimally Invasive Surgical Treatment in an Italian Public Hospital
Sep 9, 2025, 16:22 PM -
Worth Their Weight? Cost-Effectiveness and Access Decisions for GLP-1 and GIP/GLP-1 Therapies
Sep 9, 2025, 16:22 PM -
Length of Stay (LOS) and Associated Healthcare Resource Use (HCRU) for a First Infusion of Axi-cel or Lisocel in Second Line for Large B-cell Lymphoma in France: Differences Observed From Comprehensive Hospital Databases
Sep 9, 2025, 16:22 PM -
Strategies for More Cost-Effective HrHPV Screening: A Simulation Study of Pooled Testing Based on Real-World Data in Low- and Middle-Income Countries
Sep 9, 2025, 16:22 PM -
Spillover Effects on Informal and Family Caregivers' Utility: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
What Makes a Medicine Innovative? A Literature Review of Evaluation Frameworks
Sep 9, 2025, 16:22 PM -
Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Cost Trends for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Management in Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL) Treatment With Axicabtagene Ciloleucel (Axi-cel) in the US
Sep 9, 2025, 16:22 PM -
Health Utility and Indirect Costs of Neuromuscular Disease Through a Patient-Centered Lens: A National Patient and Caregiver Survey
Sep 9, 2025, 16:22 PM -
Model Behavior: A Health Economics Checklist for Sales Models
Sep 9, 2025, 16:22 PM -
Landscape of Data Sources for Real-World Observational Studies: Focus on the French Context
Sep 9, 2025, 16:22 PM -
Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements
Sep 9, 2025, 16:22 PM
